西点药业
(301130)
| 流通市值：16.34亿 | | | 总市值：21.33亿 |
| 流通股本：5862.56万 | | | 总股本：7649.47万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 52,219,200.85 | 256,405,243.38 | 192,581,520.03 | 128,969,119.73 |
| 营业收入 | 52,219,200.85 | 256,405,243.38 | 192,581,520.03 | 128,969,119.73 |
| 二、营业总成本 | 45,150,013.49 | 219,405,403.1 | 160,706,213.91 | 105,812,162.49 |
| 营业成本 | 12,302,323.21 | 60,191,953.31 | 42,667,316.81 | 27,860,842.54 |
| 税金及附加 | 1,583,440.3 | 5,940,307.43 | 4,394,436.84 | 2,912,661.56 |
| 销售费用 | 19,808,305.01 | 121,085,464.02 | 84,092,570.97 | 55,491,296.26 |
| 管理费用 | 8,861,290.1 | 24,414,623.9 | 21,723,083.66 | 14,336,502.79 |
| 研发费用 | 2,646,289.2 | 10,224,075.45 | 10,025,178.8 | 7,109,324.75 |
| 财务费用 | -51,634.33 | -2,451,021.01 | -2,196,373.17 | -1,898,465.41 |
| 其中:利息费用 | 134,609.81 | 70,294.41 | 57,272.94 | 41,058.14 |
| 其中:利息收入 | 194,440.24 | 2,558,720.74 | 2,281,544.09 | 1,959,612.21 |
| 加:公允价值变动收益 | 444,956.39 | 735,001.2 | 1,120,360.42 | 799,431.29 |
| 加:投资收益 | 390,898.01 | 4,263,802.43 | 2,767,345.52 | 1,448,902.27 |
| 资产处置收益 | - | -499,571.82 | - | - |
| 资产减值损失(新) | 7,904.73 | -609,336.95 | -471,032.23 | -460,830.54 |
| 信用减值损失(新) | -114,560.38 | -659,627.01 | -823,450.53 | -632,947.22 |
| 其他收益 | 1,063,688.8 | 6,104,473.97 | 5,205,516.81 | 4,256,203.72 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 8,862,074.91 | 46,334,582.1 | 39,674,046.11 | 28,567,716.76 |
| 加:营业外收入 | 71.49 | 385,274.39 | 54.59 | 54.59 |
| 减:营业外支出 | - | 205,277.16 | 704,671.57 | 704,303.21 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 8,862,146.4 | 46,514,579.33 | 38,969,429.13 | 27,863,468.14 |
| 减:所得税费用 | 1,210,197.44 | 6,245,780.6 | 4,902,896.89 | 3,411,753.89 |
| 六、净利润 | 7,651,948.96 | 40,268,798.73 | 34,066,532.24 | 24,451,714.25 |
| 持续经营净利润 | 7,651,948.96 | 40,268,798.73 | 34,066,532.24 | - |
| 归属于母公司股东的净利润 | 8,294,245.85 | 40,268,798.73 | 34,066,532.24 | 24,451,714.25 |
| 少数股东损益 | -642,296.89 | - | - | - |
| (一)基本每股收益 | 0.11 | 0.52 | 0.44 | 0.3 |
| (二)稀释每股收益 | 0.11 | 0.52 | 0.44 | 0.31 |
| 九、综合收益总额 | 7,651,948.96 | 40,268,798.73 | 34,066,532.24 | 24,451,714.25 |
| 归属于母公司股东的综合收益总额 | 8,294,245.85 | 40,268,798.73 | 34,066,532.24 | 24,451,714.25 |
| 归属于少数股东的综合收益总额 | -642,296.89 | - | - | - |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-26 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |